View in EDS HTML Full Text PDF Full Text

In situ treatment with a TLR9 agonist virus-like particle to promote immune responses against oral epithelial dysplasia progression.

Saved in:
Bibliographic Details
Title: In situ treatment with a TLR9 agonist virus-like particle to promote immune responses against oral epithelial dysplasia progression.
Authors: Xu Y; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA., Mcmillan A; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.; Department of Otolaryngology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA., Gupta N; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA., Lemke-Miltner CD; Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA, USA.; Department of Internal Medicine, The University of Iowa, Iowa City, IA, USA., Rataan AO; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan., Areecheewakul S; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.; Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand., Bhat DS; Department of Internal Medicine, The University of Iowa, Iowa City, IA, USA., Lanzel EA; Department of Oral Pathology, Radiology and Medicine, College of Dentistry, University of Iowa, Iowa City, IA, USA., Geary SM; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA., Simons AL; Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA, USA.; Department of Oral Pathology, Radiology and Medicine, College of Dentistry, University of Iowa, Iowa City, IA, USA.; Department of Pathology, University of Iowa, Iowa City, IA, USA.; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.; Department of Radiation Oncology, Carver College of Medicine, Iowa City, United States., Weiner GJ; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.; Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA, USA.; Department of Internal Medicine, The University of Iowa, Iowa City, IA, USA., Salem AK; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA. aliasger-salem@uiowa.edu.; Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA, USA. aliasger-salem@uiowa.edu.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 May 03; Vol. 74 (6), pp. 189. Date of Electronic Publication: 2025 May 03.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40317310
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: In situ treatment with a TLR9 agonist virus-like particle to promote immune responses against oral epithelial dysplasia progression.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.<br /><searchLink fieldCode="AU" term="%22Mcmillan+A%22">Mcmillan A</searchLink>; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.; Department of Otolaryngology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.<br /><searchLink fieldCode="AU" term="%22Gupta+N%22">Gupta N</searchLink>; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.<br /><searchLink fieldCode="AU" term="%22Lemke-Miltner+CD%22">Lemke-Miltner CD</searchLink>; Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA, USA.; Department of Internal Medicine, The University of Iowa, Iowa City, IA, USA.<br /><searchLink fieldCode="AU" term="%22Rataan+AO%22">Rataan AO</searchLink>; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.<br /><searchLink fieldCode="AU" term="%22Areecheewakul+S%22">Areecheewakul S</searchLink>; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.; Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Bhat+DS%22">Bhat DS</searchLink>; Department of Internal Medicine, The University of Iowa, Iowa City, IA, USA.<br /><searchLink fieldCode="AU" term="%22Lanzel+EA%22">Lanzel EA</searchLink>; Department of Oral Pathology, Radiology and Medicine, College of Dentistry, University of Iowa, Iowa City, IA, USA.<br /><searchLink fieldCode="AU" term="%22Geary+SM%22">Geary SM</searchLink>; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.<br /><searchLink fieldCode="AU" term="%22Simons+AL%22">Simons AL</searchLink>; Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA, USA.; Department of Oral Pathology, Radiology and Medicine, College of Dentistry, University of Iowa, Iowa City, IA, USA.; Department of Pathology, University of Iowa, Iowa City, IA, USA.; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.; Department of Radiation Oncology, Carver College of Medicine, Iowa City, United States.<br /><searchLink fieldCode="AU" term="%22Weiner+GJ%22">Weiner GJ</searchLink>; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.; Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA, USA.; Department of Internal Medicine, The University of Iowa, Iowa City, IA, USA.<br /><searchLink fieldCode="AU" term="%22Salem+AK%22">Salem AK</searchLink>; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA. aliasger-salem@uiowa.edu.; Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA, USA. aliasger-salem@uiowa.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2025 May 03; Vol. 74 (6), pp. 189. <i>Date of Electronic Publication: </i>2025 May 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40317310
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00262-025-04023-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 189
    Titles:
      – TitleFull: In situ treatment with a TLR9 agonist virus-like particle to promote immune responses against oral epithelial dysplasia progression.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Xu Y
      – PersonEntity:
          Name:
            NameFull: Mcmillan A
      – PersonEntity:
          Name:
            NameFull: Gupta N
      – PersonEntity:
          Name:
            NameFull: Lemke-Miltner CD
      – PersonEntity:
          Name:
            NameFull: Rataan AO
      – PersonEntity:
          Name:
            NameFull: Areecheewakul S
      – PersonEntity:
          Name:
            NameFull: Bhat DS
      – PersonEntity:
          Name:
            NameFull: Lanzel EA
      – PersonEntity:
          Name:
            NameFull: Geary SM
      – PersonEntity:
          Name:
            NameFull: Simons AL
      – PersonEntity:
          Name:
            NameFull: Weiner GJ
      – PersonEntity:
          Name:
            NameFull: Salem AK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 05
              Text: 2025 May 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0851
          Numbering:
            – Type: volume
              Value: 74
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Cancer immunology, immunotherapy : CII
              Type: main
ResultId 1